Literature DB >> 7858074

Clozapine for polydipsia and hyponatremia in chronic schizophrenics.

D C Henderson1, D C Goff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7858074     DOI： 10.1016/0006-3223(94)90089-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  6 in total

1.  Effect of COMT Val108/158Met genotype on risk for polydipsia in chronic patients with schizophrenia.

Authors:  Kenji Yamada; Takahiro Shinkai; Hsin-I Chen; Kensuke Utsunomiya; Jun Nakamura
Journal:  Neuromolecular Med       Date:  2014-01-18       Impact factor: 3.843

2.  Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Authors: 
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12

Review 3.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 4.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

5.  Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.

Authors:  W V Vieweg; R A Leadbetter
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

6.  Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia-hyponatremia in schizophrenia.

Authors:  Takahiro Shinkai; Vincenzo De Luca; Kensuke Utsunomiya; Shinichi Sakata; Yoshiaki Inoue; Yuko Fukunaka; Rudi Hwang; Osamu Ohmori; James L Kennedy; Jun Nakamura
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.